ShenzhenJournalofIntegratedTraditionalChineseandWesternMedicineJune2023Vol.33.No.12·64·〔文章编号〕1007-0893(2023)12-0064-03DOI:10.16458/j.cnki.1007-0893.2023.12.019补肾健脾汤治疗原发性骨质疏松症的疗效及不良反应孙双卡秦涛※(南阳市中医院,河南南阳473000)〔摘要〕目的:探讨补肾健脾汤治疗原发性骨质疏松症的疗效及不良反应。方法:选取南阳市中医院2020年3月至2021年12月收治的80例原发性骨质疏松症患者,用随机数字表法将其分对照组和观察组,各40例。对照组患者接受西医治疗,观察组患者接受补肾健脾汤治疗,比较两组患者疗效、骨密度、骨生化指标、不良反应等。结果:观察组患者治疗总有效率为95.00%,高于对照组的80.00%,差异具有统计学意义(P<0.05)。治疗后观察组患者股骨三角区、股骨粗隆、股骨颈、腰椎骨密度高于对照组,差异具有统计学意义(P<0.05)。治疗后观察组患者血钙/血肌酐、血清碱性磷酸酶低于对照组,血清钙高于对照组,差异具有统计学意义(P<0.05)。两组患者的不良反应发生率比较,差异无统计学意义(P>0.05)。结论:补肾健脾汤治疗原发性骨质疏松症,可更好的改善其骨密度、骨生化指标,提升疗效的基础上,严控药物不良反应。〔关键词〕原发性骨质疏松症;补肾健脾汤;钙尔奇片;阿伦磷酸钠片〔中图分类号〕R691.9〔文献标识码〕BAnalysisofClinicalEffectandAdverseReactionofBushenJianpiDecoctioninTreatmentofPrimaryOsteoporosisSUNShuang-ka,QINTao※(NanyangHospitalofTraditionalChineseMedicine,HenanNanyang473000)〔Abstract〕ObjectiveToexplorethecurativeeffectandadversereactionanalysisofBushenJianpidecoctionintreatingprimaryosteoporosis.MethodsAtotalof80patientswithprimaryosteoporosisadmittedtoNanyangHospitalofTraditionalChineseMedicinefromMarch2020toDecember2021wereselectedanddividedintoacontrolgroupandanobservationgroupwith40casesineachgroupbyrandomnumbertablemethod.Thecontrolgroupreceivedwesternmedicinetreatment,andtheobservationgroupreceivedBushenJianpidecoction.Thetherapeuticefficacy,bonedensity,bonebiochemicalindexesandadversereactionswerecomparedbetweenthetwogroups.ResultsThetotaleffectiverateoftheobservationgroupwas95.00%,whichwashigherthan80.00%ofthecontrolgroup,andthedifferencewasstatisticallysignific...